Intelligence / Healthtech / New Clinical Trials / McNeil AB
Clinicaltrial registered23 Oct 2026
McNeil AB
23 Oct 2026: Trial registered · A Study of Nicotine Orodispersible Tablet on Craving Relief of Male and Female Smoker Volunteers. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 23 Oct 2026
- Title
- A Study of Nicotine Orodispersible Tablet on Craving Relief of Male and Female Smoker Volunteers
- Conditions
- Smoking Cessation, Nicotine Replacements Therapy
- Phase
- Phase 2
- Study Type
- Interventional
- Status
- Recruiting
- Countries
- Canada
- Country
- Canada
- Reference
- NCT07893158
- Location
- Canada
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at McNeil AB
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
More from Canada
New Clinical Trials
17 NovAstraZenecatrial registered · A Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLCClinical17 NovNS Pharma, Inc.trial registered · A Global Phase 2 Extension Study of Brogidirsen in Boys With Duchenne Muscular DystrophyClinical16 NovBristol-Myers Squibbtrial registered · A Study of BMS-986548 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesClinical12 NovNovo Nordisk A/Strial registered · AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or BothClinical12 NovOruka Therapeutics, Inc.trial registered · An Open-label Study With Maintenance Dosing of ORKA-002 in Participants With Moderate-to-Severe Plaque PsoriasisClinical6 NovSpinal Simplicity LLCtrial registered · CANLINK: Evaluation of the Intralink Intradiscal Device for Low Back Pain Due to Degenerative Disc DiseaseClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.